Non categorizzato AbbVie to take over Cerevel Therapeutics in $8.7B deal Dicembre 7, 2023 0 commenti AbbVie Inc. revealed in a statement it will be acquiring Cerevel Therapeutics Hldg in an agreement valued at $8.7 billion or $45 per share. The deal is expected to boost AbbVie’s neuroscience por… About the author:
Get involved!
Comments